Business · 28/05/2021
FDA Revokes Emergency Use Authorization for COVID-19 Diagnostic Device
The FDA has revoked the Emergency Use Authorization for the BioFire Respiratory Panel 2.1, a COVID-19 diagnostic device, due to its reclassification as a Class II device under the FD&C Act.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →